Roswell Park Cancer Institute Clinical Trials
Sponsors / Roswell Park Cancer Institute
Roswell Park Cancer Institute is listed as the lead sponsor on 204 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 41 are in recruitment, 10 are active non-recruiting, and 111 have reached completion. 33 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Across the portfolio, planned enrollment totals 20,378 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
204
Total Trials
41
Recruiting
10
Other Active
111
Completed
33
Terminated / Withdrawn
20,378
Total Enrollment
Termination reasons: Recruitment39% · Other33% · Efficacy12% · Funding9% · Safety3% · PI/or_Site3%
Recent Terminations
- NCT06456411 Stopped Apr 2026Breast Carcinoma"PI left"
- Recurrent Chronic Lymphocytic Leukemia"Manufacturing issues"
- Lung Non-Small Cell Carcinoma"low accrual"
- Platinum-Resistant Fallopian Tube Carcinoma"Lack of funding"
- Tobacco-Related Carcinoma"low accrual"
- Frailty"COVID pandemic halted ability to enroll participants. Grant funded then ended."
- Malignant Bowel Obstruction"low accrual"
- Anatomic Stage I Breast Cancer AJCC v8"lack of resources"
- Malignant Neoplasm"difficulty with equipment"
- Health Status Unknown"Art gallery dissembled- no research goals with new art."
Active Trials (10 total)
- NCT04073745
- NCT07214298
- NCT04068649
- NCT06320717
- NCT06434064
- NCT06622005
- NCT06977503
- NCT07402577
- NCT03192397
- NCT06565260
- Healthy NANCT06681077
- Colorectal Cancer PHASE1/PHASE2NCT03965234
- Colo-rectal Cancer EARLY_PHASE1NCT06011772
- NCT06202066
- NCT07017829
- NCT07439471
- NCT04348747
- NCT06350500
- Cancer-Associated Anorexia PHASE2NCT06995508
- Glioblastoma PHASE2NCT02455557